BeyondSpring Inc

Research BeyondSpring Inc (BYSI) on Bullrun: market cap USD 73.60M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBYSI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 73.60M
• Financial periodFY2025
• Net income-USD 1.01M
• Free cash flow-USD 19.82M

Valuation Snapshot

latest market cap is USD 73.60M.

About BeyondSpring Inc

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC);

Frequently asked questions

What is BeyondSpring Inc's market cap?

BeyondSpring Inc's market capitalization is USD 73.60M.

What does BeyondSpring Inc do?

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.